BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Portia Ku

Session 4 – Exit Strategies for Early Stage New Drug Companies

Date:27 July (Wednesday)
Time:  14:00 – 15:30 (GMT+8)

Portia Ku

Partner
​O’Melveny & Myers LLP

Portia Ku, partner in O’Melveny’s New York office, is an accomplished corporate transactional lawyer who specializes in capital markets, mergers and acquisitions, venture capital and private equity financings.  Portia’s clients include public and private companies that span a variety of industries, including the technology, life sciences, healthcare, ESG and fintech sectors.  She applies her expansive technical experience, strategic execution abilities, and dedication to guide clients through highly complex transactions while ultimately helping them achieve their corporate goals.

Over her 20 plus year career, Portia has helped numerous Asia-based or global based with Asia operations biopharmaceutical and biotech companies with their successful exit strategies, primarily via IPO in Hong Kong or New York, or via M&A.  Portia embraces challenging transactions and complex issues, and takes pride in clearing paths and finding solutions for innovative companies to raise capital and expand their market reach.  Over her career she has built an enviable list of successfully advised groundbreaking and notable transactions.  Most of her clients are repeat clients who return to her for advising on their most important transactions, year in and year out.

Prior to recently relocating to New York, Portia practiced for many years in Shanghai, Hong Kong, and Silicon Valley.

Speech title & Synopsis

.

.